Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
24.91
-0.39 (-1.54%)
At close: Mar 28, 2025, 4:00 PM
24.43
-0.48 (-1.93%)
After-hours: Mar 28, 2025, 4:54 PM EDT

Pacira BioSciences Statistics

Total Valuation

PCRX has a market cap or net worth of $1.15 billion. The enterprise value is $1.31 billion.

Market Cap 1.15B
Enterprise Value 1.31B

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date May 6, 2025
Ex-Dividend Date n/a

Share Statistics

PCRX has 46.28 million shares outstanding. The number of shares has decreased by -11.03% in one year.

Current Share Class 46.28M
Shares Outstanding 46.28M
Shares Change (YoY) -11.03%
Shares Change (QoQ) +6.29%
Owned by Insiders (%) 0.92%
Owned by Institutions (%) 111.68%
Float 43.49M

Valuation Ratios

PE Ratio n/a
Forward PE 8.61
PS Ratio 1.64
Forward PS 1.52
PB Ratio 1.48
P/TBV Ratio 3.27
P/FCF Ratio 6.45
P/OCF Ratio 6.09
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.41, with an EV/FCF ratio of 7.31.

EV / Earnings n/a
EV / Sales 1.86
EV / EBITDA 7.41
EV / EBIT 13.39
EV / FCF 7.31

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.82.

Current Ratio 2.40
Quick Ratio 1.93
Debt / Equity 0.82
Debt / EBITDA 3.33
Debt / FCF 3.57
Interest Coverage 5.89

Financial Efficiency

Return on equity (ROE) is -12.08% and return on invested capital (ROIC) is 4.24%.

Return on Equity (ROE) -12.08%
Return on Assets (ROA) 3.90%
Return on Invested Capital (ROIC) 4.24%
Return on Capital Employed (ROCE) 7.85%
Revenue Per Employee $887,299
Profits Per Employee -$126,025
Employee Count 790
Asset Turnover 0.45
Inventory Turnover 2.19

Taxes

In the past 12 months, PCRX has paid $36.45 million in taxes.

Income Tax 36.45M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.22% in the last 52 weeks. The beta is 0.86, so PCRX's price volatility has been lower than the market average.

Beta (5Y) 0.86
52-Week Price Change -14.22%
50-Day Moving Average 24.70
200-Day Moving Average 19.99
Relative Strength Index (RSI) 55.86
Average Volume (20 Days) 921,521

Short Selling Information

The latest short interest is 5.93 million, so 12.82% of the outstanding shares have been sold short.

Short Interest 5.93M
Short Previous Month 5.86M
Short % of Shares Out 12.82%
Short % of Float 13.64%
Short Ratio (days to cover) 7.01

Income Statement

In the last 12 months, PCRX had revenue of $700.97 million and -$99.56 million in losses. Loss per share was -$2.15.

Revenue 700.97M
Gross Profit 448.96M
Operating Income 97.57M
Pretax Income 100.55M
Net Income -99.56M
EBITDA 176.36M
EBIT 97.57M
Loss Per Share -$2.15
Full Income Statement

Balance Sheet

The company has $484.62 million in cash and $638.85 million in debt, giving a net cash position of -$154.24 million or -$3.33 per share.

Cash & Cash Equivalents 484.62M
Total Debt 638.85M
Net Cash -154.24M
Net Cash Per Share -$3.33
Equity (Book Value) 778.35M
Book Value Per Share 16.83
Working Capital 435.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $189.39 million and capital expenditures -$10.64 million, giving a free cash flow of $178.75 million.

Operating Cash Flow 189.39M
Capital Expenditures -10.64M
Free Cash Flow 178.75M
FCF Per Share $3.86
Full Cash Flow Statement

Margins

Gross margin is 64.05%, with operating and profit margins of 13.92% and -14.20%.

Gross Margin 64.05%
Operating Margin 13.92%
Pretax Margin -9.00%
Profit Margin -14.20%
EBITDA Margin 25.16%
EBIT Margin 13.92%
FCF Margin 25.50%

Dividends & Yields

PCRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 11.03%
Shareholder Yield n/a
Earnings Yield -8.64%
FCF Yield 15.51%
Dividend Details

Analyst Forecast

The average price target for PCRX is $30.67, which is 23.12% higher than the current price. The consensus rating is "Buy".

Price Target $30.67
Price Target Difference 23.12%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 8.91%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PCRX has an Altman Z-Score of 1.65 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.65
Piotroski F-Score 6